Ascletis Pharma Inc. (FRA:2VJ)
1.350
-0.040 (-2.88%)
At close: Jan 8, 2026
Ascletis Pharma Market Cap
Ascletis Pharma has a market cap or net worth of €1.37 billion as of January 9, 2026. Its market cap has increased by 433.78% in one year.
Market Cap
1.37B
Enterprise Value
1.15B
Revenue
280.99K
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.35
Market Cap Chart
Since August 1, 2018, Ascletis Pharma's market cap has decreased from 1.71B to 1.37B, a decrease of -20.01%. That is a compound annual growth rate of -2.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 1.37B | 11.40% |
| Dec 31, 2025 | 1.23B | 240.64% |
| Dec 31, 2024 | 361.09M | 104.81% |
| Dec 29, 2023 | 176.31M | -71.49% |
| Dec 30, 2022 | 618.38M | 53.38% |
| Dec 31, 2021 | 403.17M | 21.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 1, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |